Evidence map›Paper›PMID 25830045›Full record

ArticleJournal of gastrointestinal oncology2015

Liver regeneration following repeat SBRT.

Andrew Farach, Jorge Quesada, Bin S Teh

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastrointestinal oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew Farach1 Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA ; 2 Division of Oncology, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA ; 3 Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, TX 77030, USA.
Jorge Quesada1 Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA ; 2 Division of Oncology, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA ; 3 Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, TX 77030, USA.
Bin S Teh1 Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA ; 2 Division of Oncology, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA ; 3 Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, TX 77030, USA.
Texas Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver stereotactic body radiation therapy (SBRT) is an emerging treatment option for oligometastases and may confer a survival benefit in select patients. Herein, we document the first case of liver regeneration (LR) following repeat right hepatic lobe SBRT in a woman with breast cancer metastases. Retraction of the treated lobe was significant with a near 50% volume reduction. Compensatory contralateral lobe hypertrophy was noted with a 320% volume increase. The overall liver volume remained stable, within ±5% of baseline. This case indicates that repeat liver SBRT can be delivered safely to individual patients and that compensatory contralateral lobe hypertrophy is observed to maintain a functional liver volume.

Indexed as

cirrhosisLiver regeneration (LR)metastasisradiationstereotacticstereotactic body radiation therapy (SBRT)

Identifiers

PMID25830045
PMCPMC4311083
OpenAlexW262381166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.